Search research articles
Contact Us
Filters
Showing results (81-90 of 153) with videos related to
Page
of 16
Sort By:
Blood Advances
|
July 25, 2022
Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument
Raj S Kasthuri, Shruti Chaturvedi, Sonia Thomas, et al.
Current Opinion in Hematology
|
October 16, 2007
Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis
Willem J van Heeckeren, Sharon L Sanborn, Ajita Narayan, et al.
Transfusion
|
October 11, 2011
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)
Jenny M Despotovic, Michele P Lambert, Jay H Herman, et al.
Journal of Thrombosis and Haemostasis : JTH
|
December 14, 2020
Risk of thromboembolism in patients with ALK- and EGFR-mutant lung cancer: A cohort study
Joanna Roopkumar, Shyam K Poudel, Lorenzo Gervaso, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 9, 2023
High molecular weight kininogen interactions with the homologs prekallikrein and factor XI: importance to surface-induced coagulation
Bassem M Mohammed, Mao-Fu Sun, Qiufang Cheng, et al.
Advances in Therapy
|
May 2, 2021
Efficacy and Safety of Avatrombopag in Patients with Chronic Immune Thrombocytopenia: A Systematic Literature Review and Network Meta-Analysis
Piotr Wojciechowski, Koo Wilson, Jameel Nazir, et al.
The American Journal of Pathology
|
August 26, 2003
Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay
Jacob H Rand, Xiao-Xuan Wu, Anthony S Quinn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 9, 2019
Duration of anticoagulant therapy and VTE recurrence in patients with cancer
Alok A Khorana, Keith R McCrae, Dejan Milentijevic, et al.
Blood Advances
|
November 21, 2022
Anti-HK antibody inhibits the plasma contact system by blocking prekallikrein and factor XI activation in vivo
Zu-Lin Chen, Pradeep K Singh, Katharina Horn, et al.
Thrombosis Research
|
December 4, 2014
Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations
Shruti Chaturvedi, Erin Cockrell, Ricardo Espinola, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 153) with videos related to
Sort By:
Page
of 16
Blood Advances
|
July 25, 2022
Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument
Raj S Kasthuri, Shruti Chaturvedi, Sonia Thomas, et al.
Current Opinion in Hematology
|
October 16, 2007
Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis
Willem J van Heeckeren, Sharon L Sanborn, Ajita Narayan, et al.
Transfusion
|
October 11, 2011
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)
Jenny M Despotovic, Michele P Lambert, Jay H Herman, et al.
Journal of Thrombosis and Haemostasis : JTH
|
December 14, 2020
Risk of thromboembolism in patients with ALK- and EGFR-mutant lung cancer: A cohort study
Joanna Roopkumar, Shyam K Poudel, Lorenzo Gervaso, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 9, 2023
High molecular weight kininogen interactions with the homologs prekallikrein and factor XI: importance to surface-induced coagulation
Bassem M Mohammed, Mao-Fu Sun, Qiufang Cheng, et al.
Advances in Therapy
|
May 2, 2021
Efficacy and Safety of Avatrombopag in Patients with Chronic Immune Thrombocytopenia: A Systematic Literature Review and Network Meta-Analysis
Piotr Wojciechowski, Koo Wilson, Jameel Nazir, et al.
The American Journal of Pathology
|
August 26, 2003
Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay
Jacob H Rand, Xiao-Xuan Wu, Anthony S Quinn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 9, 2019
Duration of anticoagulant therapy and VTE recurrence in patients with cancer
Alok A Khorana, Keith R McCrae, Dejan Milentijevic, et al.
Blood Advances
|
November 21, 2022
Anti-HK antibody inhibits the plasma contact system by blocking prekallikrein and factor XI activation in vivo
Zu-Lin Chen, Pradeep K Singh, Katharina Horn, et al.
Thrombosis Research
|
December 4, 2014
Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations
Shruti Chaturvedi, Erin Cockrell, Ricardo Espinola, et al.
Page
of 16